Jefferies & Co

Analysts at Jefferies & Co upgrade Powerwave Tech (NASDAQ: PWAV) from "hold" to "buy," while raising their estimates for the company. The target price for PWAV has been raised from $1.50 to $3.00. PWAV had reported its Q1 results significantly below expectations. “PWAV will likely see good...

Analysts at Jefferies & Co reiterate their "buy" rating on MEDNAX (NYSE: MD). The target price for MD has been raised from $62 to $68. MD has reported its adjusted EPS for 1Q at $0.82 and has announced its EPS guidance for 2Q at $1.00-$1.05. “MD's management team showed their cost-cutting...

Analysts at Jefferies & Co reiterate their "hold" rating on eHealth Inc (NASDAQ: EHTH), while reducing their estimates for the company. The target price for EHTH has been reduced from $19 to $15. According to Jefferies & Co, “Low visibility into health care reform's impact on carriers and...

Analysts at Jefferies & Co upgrade Powerwave Tech (NASDAQ: PWAV) from "hold" to "buy." The target price for PWAV has been raised from $1.5 to $3. PWAV has reported its Q1 results short of expectations. According to Jefferies & Co, “PWAV will likely see good demand in 2010 as wireless...

Analysts at Jefferies & Co initiate coverage of Calix (NYSE: CALX) with a "buy" rating. The target price for CALX is set to $16. According to Jefferies & Co, CALX is a direct way to play the Broadband Stimulus Plan. “The recent Frontier/Verizon transaction and the Qwest/CenturyLink deal...

Analysts at Jefferies & Co maintain their "underperform" rating on Intersil Corp (NASDAQ: ISIL), while raising their estimates for the company. The target price for ISIL has been raised from $12 to $14. Intersil has reported its Q1 results and Q2 guidance significantly above the consensus,...

Analysts at Jefferies & Co maintain their "buy" rating on Salix Pharmaceuticals Ltd (NASDAQ: SLXP). The target price for SLXP has been raised from $38 to $42. According to Jefferies & Co, the target has been raised following the FDA’s hepatic encephalopathy marketing approval for SLXP’s...

Analysts at Jefferies & Co reiterate their "buy" rating on Google (NASDAQ: GOOG). The target price for GOOG is set to $695. According to Jefferies & Co, Google has begun diverting its China traffic to its Hong Kong portal, which is uncensored. However, the fate of GOOG’s China business will...

Analysts at Jefferies & Co maintain their "buy" rating on Google (NASDAQ: GOOG). The target price for GOOG is set to $695. According to Jefferies & Co, GOOG is likely to exit from China by April 10. The impact of the exit may not significantly affect GOOG as the country accounts for $250-$...

Analysts at Jefferies & Co maintain their "buy" rating on Gen-Probe (NASDAQ: GPRO), while raising their estimates for the company. The target price for Gen-Probe is set to $54. Jefferies & Co believes that “GPRO continues to take STD market share as APTIMA and TIGRIS remain the assay/...

In a research note published in Barron’s, Jefferies & Co downgraded Southern (ticker: SO) from “buy” to “hold.” The target price for SO has been reduced from $36.50 to $33.50. According to Jefferies & Co, there is less upside potential in regulated utilities, which are not geared to benefit...

After falling for two days in a row, the shares of Calpine Corporation (NYSE: CPN) got a vote of confidence when Jefferies & Co upgraded the stock from a rating of Hold to Buy and raised the price target from $11.50 to $14.50. The 52-week trading range of Calpine Corporation is $4.76 to $14.95...

The shares of Public Service Enterprise Group (NYSE: PEG) were upgraded by Jefferies & Co from a rating of Hold to a Buy rating and the price target raised from $32 to $35. Public Service Enterprise Group closed Thursday trading up 1.08 % at $30.90. Public Service Enterprise Group has a 52-...

Shares of Constellation Energy Group, Inc (NYSE: CEG) were upgraded by Jefferies & Co from a rating of Hold to Buy and the price target raised from $37 to $41. Shares of Constellation Energy Group closed trading on Thursday at $35.94. The energy company has a 52-week trading range of $15.05 to...

Analysts at Jefferies & Co maintain their "buy" rating on Abercrombie & Fitch (NYSE: ANF). The target price for ANF is set to $50. According to Jefferies & Co, Abercrombie & Fitch has reported its Q4 EPS ahead of the consensus due to better than expected gross margins. “The...